Clinical compliance with an oral uracil/tegafur (UFT) plus leucovorin (LV) regimen as adjuvant chemotherapy in Japanese colorectal cancer patients

• MEGURO Makoto

  Department of Surgical Oncology and Gastroenterological Surgery, Sapporo Medical University School of Medicine

• FURUHATA Tomohisa

  Department of Surgical Oncology and Gastroenterological Surgery, Sapporo Medical University School of Medicine

• OKITA Kenji

  Department of Surgical Oncology and Gastroenterological Surgery, Sapporo Medical University School of Medicine

• NISHIDATE Toshihiko

  Department of Surgical Oncology and Gastroenterological Surgery, Sapporo Medical University School of Medicine

• ISHIYAMA Gentaro

  Department of Surgical Oncology and Gastroenterological Surgery, Sapporo Medical University School of Medicine

• IWAYAMA Yuji

  Department of Surgical Oncology and Gastroenterological Surgery, Sapporo Medical University School of Medicine

• KIMURA Yasutoshi

  Department of Surgical Oncology and Gastroenterological Surgery, Sapporo Medical University School of Medicine

• MIZUGUCHI Toru

  Department of Surgical Oncology and Gastroenterological Surgery, Sapporo Medical University School of Medicine

• HIRATA Koichi

  Department of Surgical Oncology and Gastroenterological Surgery, Sapporo Medical University School of Medicine

Journal

• Int J Clin Oncol

  Int J Clin Oncol 14 (5), 402-407, 2009-10-01

Keywords

• Adjuvant
• Compliance
• Leucovorin
• Toxicity
• UFT

Details

• CRID: 1571698601165503744
• NII Article ID: 10027200833
• NII Book ID: AA11086579
• ISSN: 13419625
• Web Site: https://search.jamas.or.jp/link/ui/2010112076
• Text Lang: en
• Data Source:
  • CiNii Articles